Ernexa Therapeutics Inc. Increase (Decrease) in Prepaid Expense and Other Assets
Ernexa Therapeutics Inc. (ERNA) reported Increase (Decrease) in Prepaid Expense and Other Assets of $379.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets · last filed 2026-08-06
- Ernexa Therapeutics Inc. increase (decrease) in prepaid expense and other assets for the quarter ending 2026-06-30 was $59.00K, a 68.28% decline year-over-year.
- Ernexa Therapeutics Inc. increase (decrease) in prepaid expense and other assets for the quarter ending 2026-03-31 was $320.00K.
- Ernexa Therapeutics Inc. increase (decrease) in prepaid expense and other assets for the quarter ending 2025-12-31 was $225.00K.
- Ernexa Therapeutics Inc. increase (decrease) in prepaid expense and other assets for the quarter ending 2025-09-30 was -$94.00K.
- Ernexa Therapeutics Inc. increase (decrease) in prepaid expense and other assets for fiscal 2025 was $268.00K.
- Ernexa Therapeutics Inc. increase (decrease) in prepaid expense and other assets for fiscal 2024 was -$1.32M, a 337.23% decline from fiscal 2023.
- Ernexa Therapeutics Inc. increase (decrease) in prepaid expense and other assets for fiscal 2023 was $556.00K, a 197.33% increase from fiscal 2022.
- Ernexa Therapeutics Inc. increase (decrease) in prepaid expense and other assets for fiscal 2022 was $187.00K, a 78.00% decline from fiscal 2021.
| Period end | Increase (Decrease) in Prepaid Expense and Other Assets 3 month | Increase (Decrease) in Prepaid Expense and Other Assets 3 month as first filed | Increase (Decrease) in Prepaid Expense and Other Assets 6 month | Increase (Decrease) in Prepaid Expense and Other Assets 6 month as first filed | Increase (Decrease) in Prepaid Expense and Other Assets 9 month | Increase (Decrease) in Prepaid Expense and Other Assets 9 month as first filed | Increase (Decrease) in Prepaid Expense and Other Assets 12 month | Increase (Decrease) in Prepaid Expense and Other Assets 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $59.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $379.00K 10-Q · filed 2026-08-06 | $604.00K derived: sum of 3 quarters · filed 2026-08-06 | $510.00K derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2026-03-31 | $320.00K 10-Q · filed 2026-05-11 | $545.00K derived: sum of 2 quarters · filed 2026-05-11 | $451.00K derived: sum of 3 quarters · filed 2026-05-11 | $637.00K derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-12-31 | $225.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-13 | $131.00K derived: sum of 2 quarters · filed 2026-03-13 | $317.00K derived: sum of 3 quarters · filed 2026-08-06 | $268.00K 10-K · filed 2026-03-13 | ||||
| 2025-09-30 | -$94.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | $92.00K derived: sum of 2 quarters · filed 2026-08-06 | $43.00K 10-Q · filed 2025-11-07 | -$50.00K derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-06-30 | $186.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $137.00K 10-Q · filed 2026-08-06 | $44.00K derived: sum of 3 quarters · filed 2026-08-06 | -$448.00K derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-03-31 | -$49.00K 10-Q · filed 2026-05-11 | -$142.00K derived: sum of 2 quarters · filed 2026-05-11 | -$634.00K derived: sum of 3 quarters · filed 2026-05-11 | -$561.00K derived: sum of 4 quarters · filed 2026-05-11 | ||||
| 2024-12-31 | -$93.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-13 | -$585.00K derived: sum of 2 quarters · filed 2026-03-13 | -$512.00K derived: sum of 3 quarters · filed 2026-03-13 | -$1.32M 10-K · filed 2026-03-13 | ||||
| 2024-09-30 | -$492.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | -$419.00K derived: sum of 2 quarters · filed 2025-11-07 | -$1.23M 10-Q · filed 2025-11-07 | -$1.23M 10-Q · filed 2024-11-12 | -$330.00K derived: sum of 4 quarters · filed 2025-11-07 | |||
| 2024-06-30 | $73.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-13 | -$734.00K 10-Q · filed 2025-08-13 | $162.00K derived: sum of 3 quarters · filed 2025-08-13 | $36.00K derived: sum of 4 quarters · filed 2025-08-13 | ||||
| 2024-03-31 | -$807.00K 10-Q · filed 2025-05-07 | $89.00K derived: sum of 2 quarters · filed 2025-05-07 | -$37.00K derived: sum of 3 quarters · filed 2025-05-07 | $562.00K derived: sum of 4 quarters · filed 2025-05-07 | ||||
| 2023-12-31 | $896.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-12 | $770.00K derived: sum of 2 quarters · filed 2025-03-12 | $1.37M derived: sum of 3 quarters · filed 2025-03-12 | $556.00K 10-K · filed 2025-03-12 | ||||
| 2023-09-30 | -$126.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $473.00K derived: sum of 2 quarters · filed 2024-11-12 | -$340.00K 10-Q · filed 2024-11-12 | -$728.00K derived: sum of 4 quarters · filed 2024-11-12 | ||||
| 2023-06-30 | $599.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13 | -$214.00K 10-Q · filed 2024-08-13 | -$602.00K derived: sum of 3 quarters · filed 2024-08-13 | -$754.00K derived: sum of 4 quarters · filed 2024-08-13 | ||||
| 2023-03-31 | -$813.00K 10-Q · filed 2024-05-14 | -$1.20M derived: sum of 2 quarters · filed 2024-05-14 | -$1.35M derived: sum of 3 quarters · filed 2024-05-14 | -$328.00K derived: sum of 4 quarters · filed 2024-05-14 | ||||
| 2022-12-31 | -$388.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-14 | -$540.00K derived: sum of 2 quarters · filed 2024-03-14 | $485.00K derived: sum of 3 quarters · filed 2024-03-14 | $187.00K 10-K · filed 2024-03-14 | ||||
| 2022-09-30 | -$152.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | $873.00K derived: sum of 2 quarters · filed 2023-11-13 | $575.00K 10-Q · filed 2023-11-13 | $316.00K derived: sum of 4 quarters · filed 2023-11-13 | ||||
| 2022-06-30 | $1.02M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-11 | $727.00K 10-Q · filed 2023-08-11 | $468.00K derived: sum of 3 quarters · filed 2023-08-11 | $69.00K derived: sum of 4 quarters · filed 2023-08-11 | ||||
| 2022-03-31 | -$298.00K 10-Q · filed 2023-05-11 | -$557.00K derived: sum of 2 quarters · filed 2023-05-11 | -$956.00K derived: sum of 3 quarters · filed 2023-05-11 | $594.00K derived: sum of 4 quarters · filed 2023-05-11 | ||||
| 2021-12-31 | -$259.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-20 | -$658.00K derived: sum of 2 quarters · filed 2023-03-20 | $892.00K derived: sum of 3 quarters · filed 2023-03-20 | $850.00K 10-K · filed 2023-03-20 | ||||
| 2021-09-30 | -$399.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $1.15M derived: sum of 2 quarters · filed 2022-11-14 | $1.11M 10-Q · filed 2022-11-14 | $1.11M 10-Q · filed 2021-11-12 | $1.06M derived: sum of 4 quarters · filed 2022-11-14 | |||
| 2021-06-30 | $1.55M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | $1.51M 10-Q · filed 2022-08-11 | $1.51M 10-Q · filed 2021-08-13 | $1.45M derived: sum of 3 quarters · filed 2022-08-11 | $1.44M derived: sum of 4 quarters · filed 2022-08-11 | |||
| 2021-03-31 | -$42.00K 10-Q · filed 2022-07-01 | -$41.59K 10-Q · filed 2021-05-17 | -$95.24K derived: sum of 2 quarters · filed 2022-07-01 | -$105.17K derived: sum of 3 quarters · filed 2022-07-01 | -$79.46K derived: sum of 4 quarters · filed 2022-07-01 | |||
| 2020-12-31 | -$53.24K derived: 10-K/A 12 month − 10-Q 9 month · filed 2022-07-01 | -$63.17K derived: sum of 2 quarters · filed 2022-07-01 | -$37.46K derived: sum of 3 quarters · filed 2022-07-01 | $16.00K 10-K/A · filed 2022-07-01 | -$335.00K 10-K · filed 2021-03-11 | |||
| 2020-09-30 | -$9.94K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | $15.78K derived: sum of 2 quarters · filed 2021-11-12 | $69.24K 10-Q · filed 2021-11-12 | -$353.00K 10-Q · filed 2020-11-13 | $8.24K derived: sum of 4 quarters · filed 2021-11-12 | |||
| 2020-06-30 | $25.72K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-13 | $79.17K 10-Q · filed 2021-08-13 | -$190.00K 10-Q · filed 2020-08-07 | $18.18K derived: sum of 3 quarters · filed 2021-08-13 | $96.17K derived: sum of 4 quarters · filed 2021-08-13 | |||
| 2020-03-31 | $53.46K 10-Q · filed 2021-05-17 | $254.00K 10-Q · filed 2020-05-20 | -$7.54K derived: sum of 2 quarters · filed 2021-05-17 | $70.46K derived: sum of 3 quarters · filed 2021-05-17 | $116.46K derived: sum of 4 quarters · filed 2021-05-17 | |||
| 2019-12-31 | -$61.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-11 | $17.00K derived: sum of 2 quarters · filed 2021-03-11 | $63.00K derived: sum of 3 quarters · filed 2021-03-11 | $5.00K 10-K · filed 2021-03-11 | ||||
| 2019-09-30 | $78.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-13 | $124.00K derived: sum of 2 quarters · filed 2020-11-13 | $66.00K 10-Q · filed 2020-11-13 | |||||
| 2019-06-30 | $46.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-07 | -$12.00K 10-Q · filed 2020-08-07 | ||||||
| 2019-03-31 | -$58.00K 10-Q · filed 2020-05-20 | |||||||
| 2012-12-31 | -$232.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-29 | -$494.00K derived: sum of 2 quarters · filed 2013-03-29 | -$467.00K derived: sum of 3 quarters · filed 2013-03-29 | -$432.00K 10-K · filed 2013-03-29 | ||||
| 2012-09-30 | -$262.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-09 | -$235.00K derived: sum of 2 quarters · filed 2012-11-09 | -$200.00K 10-Q · filed 2012-11-09 | -$290.00K derived: sum of 4 quarters · filed 2013-03-29 | ||||
| 2012-06-30 | $27.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-14 | $62.00K 10-Q · filed 2012-08-14 | -$28.00K derived: sum of 3 quarters · filed 2013-03-29 | -$2.00K derived: sum of 4 quarters · filed 2013-03-29 | ||||
| 2012-03-31 | $35.00K 10-Q · filed 2012-05-11 | -$55.00K derived: sum of 2 quarters · filed 2013-03-29 | -$29.00K derived: sum of 3 quarters · filed 2013-03-29 | $260.00K derived: sum of 4 quarters · filed 2013-03-29 | ||||
| 2011-12-31 | -$90.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-29 | -$64.00K derived: sum of 2 quarters · filed 2013-03-29 | $225.00K derived: sum of 3 quarters · filed 2013-03-29 | -$58.00K 10-K · filed 2013-03-29 | ||||
| 2011-09-30 | $26.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-09 | $315.00K derived: sum of 2 quarters · filed 2012-11-09 | $32.00K 10-Q · filed 2012-11-09 | $77.00K derived: sum of 4 quarters · filed 2012-11-09 | ||||
| 2011-06-30 | $289.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-14 | $6.00K 10-Q · filed 2012-08-14 | $51.00K derived: sum of 3 quarters · filed 2012-08-14 | $20.00K derived: sum of 4 quarters · filed 2012-08-14 | ||||
| 2011-03-31 | -$283.00K 10-Q · filed 2012-05-11 | -$238.00K derived: sum of 2 quarters · filed 2012-05-11 | -$269.00K derived: sum of 3 quarters · filed 2012-05-11 | |||||
| 2010-12-31 | $45.00K derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-30 | $14.00K derived: sum of 2 quarters · filed 2012-03-30 | $41.00K 10-K · filed 2012-03-30 | |||||
| 2010-09-30 | -$31.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-14 | -$4.00K 10-Q · filed 2011-11-14 | ||||||
| 2010-06-30 | $27.00K 10-Q · filed 2011-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B |